(FTNT, PWRM, NHPR, NTRS, NAVG) Stock Report from DrStockPick.com
Wednesday, June 1st, 2011Fortinet Inc. (Nasdaq:FTNT) announced that worldwide customers are using Fortinet’s FortiClient™ Endpoint Security Suite to provide broad endpoint security. With the rise in mobile workers, it’s more important than ever to help ensure that laptops and mobile devices are protected by an endpoint security solution that provides advanced security features in a uniquely modular endpoint solution. The solution also needs to allow users to load only the functionality that they require for optimized performance.
Fortinet, Inc., together with its subsidiaries, provides network security appliances and unified threat management (UTM) network security solutions to enterprises, service providers, and government entities worldwide.
***************************************************************
Power3 Medical Products, Inc (PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
Alzheimer’s is a disease that causes dementia, or loss of brain function. It affects the parts of the brain that deal with memory, thought, and language. The brain of a person with Alzheimer’s contains abnormal clumps of cellular debris and protein(plaques) and collapsed microtubules (support structures of the cell). Microtubule disintegration is caused by a malfunctioning protein called tau, which normally stabalizes the microtubules. In Alzheimer’s patients, tau proteins instead cluster together to form disabling tangles. These plaques and tangles damage the healthy cells around them. The brain also produces smaller amounts of neurotransmitters (acetylcholine, serotonin, and norepinephrine), chemicals that allow nerve cells to talk to one another.
Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Power3 Medical Products, Inc. is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
1) Breast Cancer 5) Chemotherapeutic Drug Resistance
2) Alzheimer’s Disease 6) Leukemia
3) ALS (Lou Gehrig’s Disease) 7) Gastrointestinal Disease
4) Parkinson’s Disease 8)Metabolic Syndrome
For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com
*******************************
National Health Partners, Inc. (NHPR)
National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind. The company’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage. The company is headquartered in Horsham, Pennsylvania.
CARExpress is an affordable membership program which offers significant savings to all members. CARExpress is NOT insurance! In many ways, it is the perfect complement to insurance since CARExpress offers savings on many products and services that are not included under your insurance program. Design your own benefits package to meet your specific needs.
Do you know what causes the most blindness in U.S. adults? It is an eye problem caused by diabetes, called diabetic retinopathy. Your retina is the light-sensitive tissue at the back of your eye. You need a healthy retina to see clearly. Diabetic retinopathy happens when diabetes damages the tiny blood vessels inside your retina.
If you have diabetes, you should have a complete eye exam every year. Finding and treating problems early may save your vision. Treatment often includes laser treatment or surgery.
More and more people are looking for vision services. By joining the CARExpress program, you will have access to 11,500 vision providers nationwide including: JCPenney, Target, LensCrafters, For Eyes, Sears and thousand of independents. You will be able to save an average of 10% - 50% on most frames, prescription lenses and non-prescription sunglasses. And for those of you who like to shop by mail, you can use our mail order program and save an average of 5% - 50% on most contact lenses. Not only do you receive significant savings on eyewear, but Laser Vision Correction (LASIK) is also included in this program. Special discounts on eye examinations at participating locations where approved.
National Health Partners Inc recently announced the launch of a new network marketing program by one of its strategic partners, Xpress Healthcare, LLC. Xpress Healthcare has teamed up with CARExpress in an effort to revolutionize the discount healthcare industry while at the same time bringing financial freedom to families across the nation. By the end of the second quarter of 2011, Xpress Healthcare anticipates adding over 100 new brokers both participating in and promoting National Health Partners’ CARExpress program and should enroll over 2,500 new members.
Xpress also expects its growth to accelerate in the 3rd quarter as it anticipates recruiting an additional 200 new brokers which should generate over 10,000 new CARExpress sales. According to National Health Partners, Offering tremendous growth potential, Xpress Healthcare is well positioned to become the leading marketing arm for its CARExpress and now Strong Sales are projected for 2nd Quarter from this new strategic partnership.
Please visit its website at www.nationalhealthpartners.com
***************************************************************
Northern Trust Corporation (Nasdaq:NTRS) announced that it has hired 30-year veteran Clive Bellows as Country Head, Ireland. Bellows, who will be based in Northern Trust’s Dublin office, will have responsibility for leading the company’s Irish operations. He will also play a key role in ensuring the smooth integration of Bank of Ireland Securities Services, which Northern Trust announced it intended to acquire in late February this year. Bellows will report to Toby Glaysher, head of Global Fund Services in Europe.
Northern Trust Corporation, through its subsidiaries, provides asset servicing, fund administration, investment management, banking, and fiduciary solutions for corporations, institutions, and individuals worldwide.
***************************************************************
Navigators Group Inc. (Nasdaq:NAVG) announced that its Board of Directors has adopted a share repurchase program for up to $50 million of the Company’s common stock. This repurchase program is in addition to the Company’s existing $65 million share repurchase program, announced in November 2009, pursuant to which 1,111,608 shares have been purchased at an aggregate purchase price of $50.2 million. Repurchases may be made from time to time at prevailing prices in open market or privately negotiated transactions through December 31, 2011.
The Navigators Group, Inc., an international insurance holding company, engages in the underwriting and management of property and casualty insurance in the United States, the United Kingdom, Belgium, and Sweden.
**************************************************************
**************************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).



TSM, Taiwan Semiconductor Manufacturing Company, Ltd.
ZMGD, Zamage Digital Art Imaging, Inc., ZMGD.PK
NTRS, Northern Trust Corporation





